Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Clinical trial NCT02087579 · COMPLETED

Trial details

NCT number: NCT02087579
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Psychotic Disorders Schizophrenia Bipolar Disorder Depressive Disorder

Start date: 2014-02-01
Primary completion: 2014-10-01
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.